PAION Pharma

PAION Pharma GmbH is a specialised pharmaceutical company, focused on the development and distribution of life-saving medicines with innovative active ingredients. With over 20 years of pharmaceutical expertise, we are committed to making a significant contribution to improving patient care.

Since February 2024, we have operated as an independent subsidiary of Humanwell Healthcare Group, strengthening our global presence and capabilities. This strategic partnership allows us to expand our distribution networks, enhance our research and development efforts, and secure new opportunities for growth in Europe and beyond..

Approach to Healthcare:

Our mission is to deliver patient-centred, innovative solutions with a strong focus on anaesthesiology and intensive care. Our products are used in outpatient and inpatient sedation, anaesthesia, and intensive care. They are also used in the treatment of septic and distributive shock, as well as in bacterial intra-abdominal infections.

Impact of Products/Services on Healthcare:

Innovation at PAION Pharma is driven by a strong focus on differentiated mechanisms of action and clinical relevance in real world hospital practice. We continuously invest in clinical development, post authorisation evidence generation, and medical education to support optimal use of our products. Through close collaboration with healthcare professionals and academic partners, we translate scientific insights into practical solutions that address current challenges in anaesthesia, intensive care, and infectious diseases.

Innovation:

Innovation at PAION Pharma is driven by a strong focus on differentiated mechanisms of action and clinical relevance in real world hospital practice. We continuously invest in clinical development, post authorisation evidence generation, and medical education to support optimal use of our products. Through close collaboration with healthcare professionals and academic partners, we translate scientific insights into practical solutions that address current challenges in anaesthesia, intensive care, and infectious diseases.

Future Direction:

PAION Pharma’s future direction is focused on expanding access to specialised hospital medicines across Europe and selected international markets, while further strengthening our presence in anaesthesiology and critical care. We aim to advance our pipeline, broaden indications where clinically justified, and continue generating robust clinical and real world evidence. Through strategic partnerships and a patient focused approach, we remain committed to delivering meaningful innovations that support healthcare professionals and improve outcomes in critically ill patients.